Premium Nahrungsergänzungsmittel | artgerecht

Fetuin B: Function, Significance & Biomarker

Fetuin B is a glycoprotein produced mainly in the liver that plays a key role in metabolic processes, insulin signaling, and reproductive function.

Regular tips about health Regular tips about health

Things worth knowing about "Fetuin B"

Fetuin B is a glycoprotein produced mainly in the liver that plays a key role in metabolic processes, insulin signaling, and reproductive function.

What is Fetuin B?

Fetuin B is a glycoprotein belonging to the fetuin family, primarily synthesized in the liver and secreted into the bloodstream. It is part of the cystatin superfamily and is closely related to Fetuin A, another important serum protein. The name is derived from the Latin word fetus, as these proteins were originally discovered in high concentrations in fetal serum. In humans, Fetuin B is encoded by the FETUB gene.

Biological Functions

Fetuin B serves several important functions in the human body:

Inhibition of insulin signaling: Fetuin B can inhibit the insulin receptor and the IGF-1 receptor (Insulin-like Growth Factor 1), thereby influencing the insulin sensitivity of cells.
Regulation of glucose metabolism: Elevated levels of Fetuin B in the blood are associated with reduced glucose tolerance and increased insulin resistance.
Role in fertility: Research has shown that Fetuin B is involved in the zona pellucida reaction of egg cells. It blocks the enzyme ovastacin, which normally hardens the zona pellucida (the outer shell of the egg cell) after fertilization to prevent multiple fertilizations (polyspermy).
Modulation of inflammation: As a so-called hepatokine (a signaling molecule secreted by the liver), Fetuin B may be involved in systemic inflammatory processes.

Clinical Relevance and Associated Conditions

Insulin Resistance and Type 2 Diabetes

Several clinical studies have demonstrated elevated Fetuin B concentrations in the blood of individuals with insulin resistance, metabolic syndrome, and type 2 diabetes. It is hypothesized that Fetuin B acts as a hepatic signal influencing communication between the liver and other tissues such as muscle and adipose tissue, thereby contributing to the development of metabolic disorders.

Non-Alcoholic Fatty Liver Disease (NAFLD)

Altered Fetuin B levels have also been observed in patients with non-alcoholic fatty liver disease (NAFLD). Since the liver is the primary site of Fetuin B production, liver diseases can directly affect the concentration of this protein in the blood.

Polycystic Ovary Syndrome (PCOS)

Studies suggest that women with polycystic ovary syndrome (PCOS) exhibit altered Fetuin B levels. Since PCOS is frequently associated with insulin resistance, Fetuin B is being discussed as a potential biomarker for this condition.

Cardiovascular Disease

Emerging research suggests that Fetuin B may also be relevant in the context of cardiovascular disease, given that insulin resistance and metabolic syndrome are well-established risk factors for heart disease.

Fetuin B as a Biomarker

Due to its associations with various metabolic disorders, Fetuin B is being intensively investigated as a potential biomarker in diagnostics. Measuring Fetuin B levels in blood serum could in the future help identify patients at risk for metabolic and reproductive conditions at an early stage. At present, however, routine clinical measurement of Fetuin B is not yet widespread and remains primarily within the scope of scientific research.

Difference Between Fetuin A and Fetuin B

Fetuin A and Fetuin B are related but functionally distinct proteins. Fetuin A (also known as alpha-2-Heremans-Schmid glycoprotein) is much more extensively studied and plays a role in inhibiting the calcification of blood vessels, among other functions. Fetuin B, on the other hand, is more directly involved in fertility regulation and insulin signaling. Both proteins are primarily produced in the liver and secreted into the bloodstream.

References

Meier C. et al. - Fetuin-B, a liver-derived plasma protein, is associated with insulin resistance and metabolic syndrome. Diabetes Care, 2014.
Dietzel E. et al. - Fetuin-B, a member of the fetuin cluster, is a candidate endogenous cysteine-protease inhibitor. Biochemical Journal, 2003.
Weikert C. et al. - Plasma fetuin-B levels and risk of type 2 diabetes. Journal of Clinical Endocrinology and Metabolism, 2015.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.